✦ LIBER ✦

5501 ORAL Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME)

✍ Scribed by Vermorken, J.B.; Hitt, R.; Geoffrois, L.; Erfan, J.; Kawecki, A.; Zabolotnyy, D.; Schueler, A.; Knecht, R.; Benasso, M.; Kienzer, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2, open-label, 1:1 randomized cont

✍ Ruzsa, A.; Sen, M.; Evans, M.; Lee, L. W.; Hideghety, K.; Rottey, S.; Klimak, P. 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 487 KB

8585 POSTER Efficacy of Cetuximab Alone

✍ Fekih, M.; Ferrand, F.R.; Saada, E.; Hamdan, D.; Desmaris, R.; Schilf, A.; Guiga 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Safety and Efficacy of Panitumumab (pmab

✍ J. Vermorken; J. Stöhlmacher; K. Oliner; C. Villanueva; P. Foa; E. Winquist; L. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Impact of tumor HPV status on outcome in

✍ Vermorken, J. B.; Psyrri, A.; Mesia, R.; Peyrade, F.; Beier, F.; de Blas, B.; Ce 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 176 KB

47 POSTER A phase II study of Sorafenib

✍ C. Elser; L. Siu; E. Winquist; M. Agulnik; G. Pond; S. Chin; P. Francis; R. Chei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

97 Phase I study of cetuximab (C225)in c

✍ J. Bourhis; F. Rivera; R. Mesia; A. Awada; L. Geoffrois; C. Borel; L. Duck; E. B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB